AHK-Cu

Also known as: Tripeptide-3 Copper, Alanine-Histidine-Lysine Copper

A copper tripeptide for hair growth and skin rejuvenation with growth factor activation.

Overview

AHK-Cu is a copper-binding tripeptide (Ala-His-Lys) that promotes hair follicle growth and skin health. It works synergistically with GHK-Cu and has shown particular efficacy for hair regrowth and wound healing applications.

Mechanism of Action

Binds copper ions and delivers them to tissues. Stimulates hair follicle stem cells and dermal papilla cells. Upregulates growth factors including VEGF and FGF. Enhances extracellular matrix production.

Pharmacokinetics

Topical application preferred. Copper peptides penetrate skin well. Half-life in skin ~hours.

Dosing Protocols

Note: These are research protocols from literature. This is not medical advice.

1

Hair Growth

Dose

1-5% solution

Frequency

1-2x daily

Duration

3-6 months

Apply to scalp

2

Skin Rejuvenation

Dose

0.5-2% serum

Frequency

1-2x daily

Duration

Ongoing

Combine with GHK-Cu

Stacking Recommendations

Peptides that may be combined based on complementary mechanisms in research settings.

Rationale: Complementary copper peptides

Synergy: Enhanced hair and skin regeneration

Research Areas

Hair LossAlopeciaSkin AgingWound HealingFollicle StimulationCollagen Synthesis

Key Research Findings

  • 1Increased hair follicle size and growth rate
  • 2Enhanced dermal papilla cell proliferation
  • 3Synergistic effects with GHK-Cu
  • 4Improved wound closure in skin studies

Side Effects & Contraindications

Reported Side Effects

  • Skin irritation (rare)
  • Redness at application site

Contraindications

  • Wilson's disease
  • Copper sensitivity
  • Open wounds (high concentration)

Safety Considerations

Generally safe topically. Avoid in Wilson's disease. May cause skin irritation in sensitive individuals.

Storage Requirements

Store at room temperature, protect from light

Scientific References

Quick Reference

Sequence
Ala-His-Lys-Cu
Molecular Weight
~402 g/mol
Half-Life
Variable (topical)
Bioavailability
Topical application
Research Stage
preclinical
Administration
Topical (serum, solution)